FDA
-
GALT’s Best Day in a Year: FDA Opens the Door to Belapectin’s Decisive Trial
Biotech investors are waking up to a different market this morning. The usual cautious positioning has given way…
-
Ernexa Therapeutics Targets Q3 2026 IND Filing for ERNA-101
CAMBRIDGE, Mass., June 17 — Ernexa Therapeutics Inc. has announced significant progress in the development of its lead…
Most read
-
Nvidia shares fall 3% as traders open $9.1M short on Huang spy scandal
-
Japan Tobacco’s 272-yen dividend at risk as Putin seizes Russian assets, stock crashes 19%
-
Nasdaq Suffers Biggest Drop in 19 Months as AI Regulatory Fears Trigger Market Sell-Off
-
Citi Links Hormuz Reopening to Fed Rate Cuts and $5,000 Gold Target
-
Airline Stocks to Watch: Fuel Costs, Earnings, and Oil Volatility Drive Sector Focus
-
How Canada’s Real-Time Rail Modernizes Financial Networks and Boosts Business Efficiency
-
Boeing 777 Freighter Conversions Face Supply Crunch as New Jets Delay
-
Teen Pilots Rise: Safety Rules and Training Under Scrutiny
-
Boeing 777X First Delivery Slips to Twenty Twenty Seven Nearly Decade Late
-
Senate Demand on Musk Signals New Limits for Starlink Users
-
Why Fraud and Phishing Now Dominate Gallagher New Zealand Cyber Insurance Claims
-
Cotality Report: Louisiana Leads U.S. States in Extreme Weather Homeowner Losses
-
Home Depot Stock Jumps 7% as Democrats Sweep Congress and Housing Hopes Rise
-
Small Business Owners Face Harsh Collection on Pandemic Loans
-
Why 7.4% Mortgage Rates Freeze Markets While 1970s Double-Digit Rates Did Not
-
How Nigeria’s Lithium Factories Could Reshape Africa’s EV Battery Costs and Energy Security
-
Spain Withholds 12% of Olive Oil to Prop Up Prices
-
Kotak Neo’s Banerjee Ties Gold, Rupee and Copper to Crude Volatility and Fed Rate Hikes
-
El Niño and Iran War Drive Agricultural Commodity Prices to New Highs
-
ICE Brent Hovers Near $110 as Middle East Tensions Keep Risk Premium High